Granted Patent B2

US 12,274,889 · App. 17/812,974 · Granted Apr 15, 2025

Inventors: Xusheng Zhang (Shoreview, MN); Jian Cao (Shoreview, MN); Saul E. Greenhut (Denver, CO); Robert W. Stadler (Shoreview, MN)

Assignee: Medtronic, Inc.

A61N1/3987A61B5/29A61B5/352A61N1/3925A61N1/3956A61B5/0002A61B5/363

Abstract

Claims (76)

1. A medical device comprising:

a sensing circuit configured to:

receive a plurality of cardiac electrical signals;

sense a first plurality of R-waves from a first cardiac electrical signal of the plurality of cardiac electrical signals; and

sense a second plurality of R-waves from a second cardiac electrical signal of the plurality of cardiac electrical signals; and

a control circuit configured to:

detect a first threshold number of tachyarrhythmia intervals from the first plurality of R-waves;

detect a second threshold number of tachyarrhythmia intervals from the second plurality of R-waves, wherein the second threshold number of tachyarrhythmia intervals is less than the first threshold number of tachyarrhythmia intervals;

detect a tachyarrhythmia episode in response to detecting at least the first threshold number of tachyarrhythmia intervals and the second threshold number of tachyarrhythmia intervals; and

a therapy delivery circuit configured to deliver an anti-tachyarrhythmia therapy in response to the control circuit detecting the tachyarrhythmia episode.

2. The medical device of claim 1 , wherein the control circuit is further configured to:

determine if a rejection rule is met based on an analysis of the plurality of cardiac electrical signals; and

detect the tachyarrhythmia in response to detecting at least the first threshold number of tachyarrhythmia intervals and the second threshold number of tachyarrhythmia intervals and determining that the rejection rule is not met.

3. The medical device of claim 2 , further comprising a memory configured to buffer at least one segment from the plurality of cardiac electrical signals in response to an R-wave being sensed from the plurality of cardiac electrical signals,

wherein the control circuit is further configured to analyze the at least one segment of the plurality of cardiac electrical signals to determine if the rejection rule is met.

4. The medical device of claim 3 , further comprising processing circuitry for determining a notch-filtered difference signal from the at least one segment from the plurality of cardiac electrical signals;

wherein the control circuit is configured to analyze the notch-filtered difference signal for determining if the rejection rule is met.

5. The medical device of claim 1 , wherein the control circuit is further configured to:

determine from the plurality of cardiac electrical signals one or more gross morphology parameter(s);

determine that a noise rejection rule is not met based on the one or more gross morphology parameter(s); and

detect the tachyarrhythmia episode in response to detecting at least the first threshold number of tachyarrhythmia intervals and the second threshold number of tachyarrhythmia intervals and the noise rejection rule not being met.

6. The medical device of claim 5 , wherein the control circuit is further configured to determine the one or more gross morphology parameter(s) by determining at least one of a low slope content, a noise pulse count or a rectified amplitude.

7. The medical device of claim 1 , wherein the control circuit is further configured to:

determine one or more morphology matching score(s) from the plurality of cardiac electrical signals;

determine that a beat morphology rejection rule is not met based the one or more morphology matching scores; and

detect the tachyarrhythmia episode in response to detecting at least the first threshold number of tachyarrhythmia intervals and the second threshold number of tachyarrhythmia intervals and the beat morphology rejection rule not being met.

8. The medical device of claim 1 , wherein the control circuit is further configured to:

determine one or more T-wave oversensing parameter(s) from the plurality of cardiac electrical signals;

determine that a T-wave oversensing rejection rule is not met based on the one or more T-wave oversensing parameter(s); and

detect the tachyarrhythmia episode in response to detecting at least the first threshold number of tachyarrhythmia intervals and the second threshold number of tachyarrhythmia intervals and the T-wave oversensing rejection rule not being met.

9. The medical device of claim 1 , wherein the control circuit is further configured to:

determine maximum amplitudes from the plurality of cardiac electrical signals;

determine that a noise rejection rule is not met based on the maximum amplitudes; and

detect the tachyarrhythmia episode in response to detecting at least the first threshold number of tachyarrhythmia intervals and the second threshold number of tachyarrhythmia intervals and the noise rejection rule not being met.

10. A method comprising:

receiving by processing circuitry of a medical device a plurality of cardiac electrical signals;

sensing a first plurality of R-waves from a first cardiac electrical signal of the plurality of cardiac electrical signals;

sensing a second plurality of R-waves from a second cardiac electrical signal of the plurality of cardiac electrical signals; and

detecting a first threshold number of tachyarrhythmia intervals from the first plurality of R-waves;

detecting a second threshold number of tachyarrhythmia intervals from the second plurality of R-waves, wherein the second threshold number of tachyarrhythmia intervals is less than the first threshold number of tachyarrhythmia intervals;

detecting a tachyarrhythmia episode in response to detecting at least the first threshold number of tachyarrhythmia intervals and the second threshold number of tachyarrhythmia intervals; and

delivering an anti-tachyarrhythmia therapy by a therapy delivery circuit in response to the detected tachyarrhythmia episode.

11. The method of claim 10 , further comprising:

determining if a rejection rule is met based on an analysis of the plurality of cardiac electrical signals; and

detecting the tachyarrhythmia in response to detecting at least the first threshold number of tachyarrhythmia intervals and the second threshold number of tachyarrhythmia intervals and determining that the rejection rule is not met.

12. The method of claim 11 , further comprising:

buffering in a memory of the medical device at least one segment from the plurality of cardiac electrical signals in response to an R-wave being sensed from the plurality of cardiac electrical signals; and

analyzing the at least one segment of the plurality of cardiac electrical signals to determine if the rejection rule is met.

13. The method of claim 12 , further comprising:

determining a notch-filtered difference signal from the at least one segment from the plurality of cardiac electrical signals; and

analyzing the notch-filtered difference signal for determining if the rejection rule is met.

14. The method of claim 10 , further comprising:

determining from the plurality of cardiac electrical signals one or more gross morphology parameter(s);

determining that a noise rejection rule is not met based on the one or more gross morphology parameter(s); and

detecting the tachyarrhythmia episode in response to detecting at least the first threshold number of tachyarrhythmia intervals and the second threshold number of tachyarrhythmia intervals and the noise rejection rule not being met.

15. The method of claim 14 , further comprising determining the one or more gross morphology parameter(s) by determining at least one of a low slope content, a noise pulse count or a rectified amplitude.

16. The method of claim 10 , further comprising:

determining one or more morphology matching score(s) from the plurality of cardiac electrical signals;

determining that a beat morphology rejection rule is not met based the one or more morphology matching scores; and

detecting the tachyarrhythmia episode in response to detecting at least the first threshold number of tachyarrhythmia intervals and the second threshold number of tachyarrhythmia intervals and the beat morphology rejection rule not being met.

17. The method of claim 10 , further comprising:

determining one or more T-wave oversensing parameter(s) from the plurality of cardiac electrical signals;

determining that a T-wave oversensing rejection rule is not met based on the one or more T-wave oversensing parameter(s); and

detecting the tachyarrhythmia episode in response to detecting at least the first threshold number of tachyarrhythmia intervals and the second threshold number of tachyarrhythmia intervals and the T-wave oversensing rejection rule not being met.

18. The method of claim 10 , further comprising:

determining maximum amplitudes from the plurality of cardiac electrical signals;

determining that a noise rejection rule is not met based on the maximum amplitudes; and

detecting the tachyarrhythmia episode in response to detecting at least the first threshold number of tachyarrhythmia intervals and the second threshold number of tachyarrhythmia intervals and the noise rejection rule not being met.

19. A non-transitory, computer-readable medium comprising a set of instructions that, when executed by processing circuitry of a medical device, cause the medical device to:

receive by processing circuitry of a medical device a plurality of cardiac electrical signals;

sense a first plurality of R-waves from a first cardiac electrical signal of the plurality of cardiac electrical signals;

sense a second plurality of R-waves from a second cardiac electrical signal of the plurality of cardiac electrical signals; and

detect a first threshold number of tachyarrhythmia intervals from the first plurality of R-waves;

detect a second threshold number of tachyarrhythmia intervals from the second plurality of R-waves, wherein the second threshold number of tachyarrhythmia intervals is less than the first threshold number of tachyarrhythmia intervals;

detect a tachyarrhythmia episode in response to detecting at least the first threshold number of tachyarrhythmia intervals and the second threshold number of tachyarrhythmia intervals; and

deliver an anti-tachyarrhythmia therapy in response to the detected tachyarrhythmia episode.

Assignments (1)

Continuity (5)

References Cited (54)